CORRECTION: Agilon Health Raises FY2026 Sales Guidance from $5.680B-$5.805B to $5.775B-$5.860B vs $5.719B Est

Benzinga Newsdesk www.benzinga.com Positive 93.5%

Neg 0% Neu 0% Pos 93.5%

Agilon Health (NYSE:AGL) raises FY2026 sales outlook from $5.680 billion-$5.805 billion to $5.775 billion-$5.860 billion vs $5.719 billion estimate.